PCT vs TRT bridging: what the evidence actually says

What did @alphaclubsupps actually say?

The creator made three distinct claims. First, if you plan to return to a steroid cycle, skip PCT entirely and "drop down to TRT" instead, because "blast and cruise" is easier on the body than repeatedly stopping and starting. Second, the old-school PCT protocol, two weeks off testosterone followed by four weeks of clomid and nolvadex, is probably not long enough. Third, six to eight weeks of PCT is more appropriate, and enclomiphene alone is a viable modern alternative to the traditional clomid-plus-nolvadex stack.

The video is directed at people already using performance-enhancing doses of testosterone who are deciding whether to come off. This is not a TRT education video in any conventional medical sense. It is cycling advice dressed in TRT language, and that framing matters for how you interpret every claim that follows.

Does the science back this up?

Partially, yes. The claim that four weeks of PCT is insufficient for many users has real support. The enclomiphene data is early but genuinely promising. The blast-and-cruise framing, however, papers over serious risks by calling them a kindness.

On PCT duration: a 2023 review by Rahnema et al. in Fertility and Sterility noted that hypogonadism following supraphysiologic androgen exposure can persist for months and that recovery timelines are highly variable, correlated with cycle length and total androgen exposure. Four weeks of SERMs may restore LH surge in some men but leaves others with suppressed HPG axis function. The six-to-eight-week recommendation has a reasonable basis here.

On enclomiphene: a 2019 trial by Wiehle et al. in Andrology found enclomiphene raised testosterone and gonadotropins more consistently than clomiphene, with fewer estrogenic side effects, since it lacks the zuclomiphene isomer. The "simpler" framing is defensible. However, enclomiphene is not FDA-approved for PCT and its use in this context is entirely off-label.

On blast-and-cruise: there is no peer-reviewed evidence that indefinite suppression is safer than attempted HPG recovery. The claim that repeated cycling is harder on the body than permanent suppression is an opinion presented as established fact.

What did they get wrong (or right)?

They got the PCT duration point broadly right. The four-week standard is outdated and the literature does support longer recovery windows for heavily suppressed individuals. Credit where it is due.

They got the blast-and-cruise framing wrong, or at least dangerously incomplete. Saying it is "far kinder on the body" to stay on supraphysiologic testosterone indefinitely rather than attempt recovery ignores documented cardiovascular risks. A 2017 study by Baggish et al. in Circulation found that long-term anabolic steroid users showed significantly impaired left ventricular function and reduced coronary flow reserve compared to non-users and former users. The former-user group showed partial recovery. Staying on permanently forecloses that recovery window.

The enclomiphene recommendation is reasonable in concept, but the video presents no caveats about sourcing, prescriber involvement, or the fact that enclomiphene is not approved for this indication. Listeners may interpret this as a simple over-the-counter fix, which it is not in most jurisdictions.

The advice to comment "induct TRT" to get protocol help is also worth flagging. Funneling viewers into personalized protocol advice via social media comments is not a regulated clinical pathway.

What should you actually know?

PCT is not a standardized medical protocol. It is a harm-reduction practice developed within the bodybuilding community and studied inconsistently. No major endocrinology society, including the Endocrine Society or the American Urological Association, currently publishes guidelines on PCT for anabolic steroid users, largely because recommending how to recover from illicit supraphysiologic use falls outside their scope.

What the evidence does support is this: HPG axis suppression duration correlates with cycle length and androgen potency. Recovery is not guaranteed. A 2015 case series by Osterberg et al. in The Journal of Sexual Medicine documented persistent hypogonadism lasting over a year in some former anabolic steroid users even after attempted PCT. If you are considering coming off exogenous testosterone after extended use, working with a physician who can monitor LH, FSH, and total testosterone levels throughout recovery is the only evidence-informed path. A TikTok comment thread is not a substitute.

Enclomiphene is genuinely interesting pharmacology but access varies. In the US it requires a prescription. Sourcing it through research chemical suppliers introduces contamination and dosing risks that the video does not mention at all.